Psychedelic Drug Monitoring Services (0820T-0822T) (March 2024)

Why This Topic Matters

It helps readers identify a new CPT reporting area for supervised psychedelic medication therapy and understand the surrounding documentation and session structure discussed in the source.

Article Sections

1. Psychedelic Drug Monitoring Services (0820T-0822T)

   Introduces the CPT 2024 update and the new Category III service category discussed in the article. Provides a high-level summary of the code set additions and the related guideline framework.

2. Continuous In-Person Monitoring and Intervention During Psychedelic Medication Therapy

   Describes the general service context for supervised psychedelic medication therapy and the role of in-person monitoring and support. Explains the broader therapeutic setting and the type of personnel involvement addressed by the update.

3. Clinical Example (0820T) / Description of Procedure (0820T)

   Presents an illustrative scenario and related procedure narrative for the primary monitoring service. Shows the kind of clinical setting and session flow discussed in the article.

4. Clinical Example (0821T) / Description of Procedure (0821T)

   Presents an illustrative scenario and related procedure narrative for the concurrent participation of a second professional. Focuses on the circumstances in which additional in-room support is discussed.

5. Clinical Example (0822T) / Description of Procedure (0822T)

   Presents an illustrative scenario and related procedure narrative for concurrent clinical staff participation. Covers the same general service environment from the staffing perspective.